vs
Ladder Capital Corp（LADR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Ladder Capital Corp的1.6倍（$35.5M vs $22.3M），Ladder Capital Corp净利率更高（71.0% vs -304.2%，领先375.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -18.0%），Ladder Capital Corp自由现金流更多（$78.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -22.5%）
Ladder Capital Corp是一家总部位于美国的领先商业地产金融机构，核心业务包括发放优先级商业抵押贷款、夹层债务，投资商业地产抵押担保证券及直接持有商业地产资产，服务覆盖美国多地的地产所有者、运营商与开发商。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LADR vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.3M | $35.5M |
| 净利润 | $15.9M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 69.5% | -304.8% |
| 净利率 | 71.0% | -304.2% |
| 营收同比 | -18.0% | 681.7% |
| 净利润同比 | -49.4% | 39.6% |
| 每股收益（稀释后） | $0.13 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $22.3M | $35.5M | ||
| Q3 25 | $27.8M | $5.2M | ||
| Q2 25 | $21.5M | $19.2M | ||
| Q1 25 | $20.3M | $14.7M | ||
| Q4 24 | $27.2M | $4.5M | ||
| Q3 24 | $38.4M | $26.1M | ||
| Q2 24 | $34.3M | $14.4M | ||
| Q1 24 | $37.1M | $13.8M |
| Q4 25 | $15.9M | $-108.1M | ||
| Q3 25 | $19.2M | $-162.3M | ||
| Q2 25 | $17.1M | $-171.9M | ||
| Q1 25 | $11.6M | $-202.5M | ||
| Q4 24 | $31.3M | $-178.9M | ||
| Q3 24 | $27.6M | $-95.8M | ||
| Q2 24 | $32.1M | $-97.5M | ||
| Q1 24 | $16.4M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 69.5% | -304.8% | ||
| Q3 25 | 72.4% | -3327.6% | ||
| Q2 25 | 96.7% | -916.8% | ||
| Q1 25 | 52.7% | -1297.9% | ||
| Q4 24 | — | -4042.4% | ||
| Q3 24 | 74.1% | -377.1% | ||
| Q2 24 | 90.4% | -697.4% | ||
| Q1 24 | 49.4% | -698.4% |
| Q4 25 | 71.0% | -304.2% | ||
| Q3 25 | 69.0% | -3135.3% | ||
| Q2 25 | 79.5% | -894.2% | ||
| Q1 25 | 56.8% | -1373.3% | ||
| Q4 24 | 115.1% | -3935.5% | ||
| Q3 24 | 71.7% | -367.5% | ||
| Q2 24 | 93.6% | -676.6% | ||
| Q1 24 | 44.2% | -662.4% |
| Q4 25 | $0.13 | $-0.17 | ||
| Q3 25 | $0.15 | $-0.36 | ||
| Q2 25 | $0.14 | $-0.41 | ||
| Q1 25 | $0.09 | $-0.50 | ||
| Q4 24 | $0.25 | $-0.56 | ||
| Q3 24 | $0.22 | $-0.34 | ||
| Q2 24 | $0.26 | $-0.40 | ||
| Q1 24 | $0.13 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $38.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $1.5B | $1.1B |
| 总资产 | $5.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $38.0M | $743.3M | ||
| Q3 25 | $49.4M | $659.8M | ||
| Q2 25 | $134.9M | $525.1M | ||
| Q1 25 | $479.8M | $500.5M | ||
| Q4 24 | $1.3B | $594.4M | ||
| Q3 24 | $1.6B | $427.6M | ||
| Q2 24 | $1.2B | $474.3M | ||
| Q1 24 | $1.2B | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $919.1M | ||
| Q1 25 | $1.5B | $933.9M | ||
| Q4 24 | $1.5B | $1.0B | ||
| Q3 24 | $1.5B | $524.6M | ||
| Q2 24 | $1.5B | $584.4M | ||
| Q1 24 | $1.5B | $401.2M |
| Q4 25 | $5.2B | $1.5B | ||
| Q3 25 | $4.7B | $1.4B | ||
| Q2 25 | $4.5B | $1.3B | ||
| Q1 25 | $4.5B | $1.3B | ||
| Q4 24 | $4.8B | $1.4B | ||
| Q3 24 | $4.8B | $726.5M | ||
| Q2 24 | $4.8B | $775.9M | ||
| Q1 24 | $5.3B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $78.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | 352.4% | -133.1% |
| 资本支出强度资本支出/营收 | 37.4% | 3.5% |
| 现金转化率经营现金流/净利润 | 5.49× | — |
| 过去12个月自由现金流最近4个季度 | $118.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $87.0M | $-46.1M | ||
| Q3 25 | $26.3M | $-117.4M | ||
| Q2 25 | $44.0M | $-76.4M | ||
| Q1 25 | $-28.7M | $-132.0M | ||
| Q4 24 | $133.9M | $-115.4M | ||
| Q3 24 | $169.0M | $-59.2M | ||
| Q2 24 | $45.4M | $-82.2M | ||
| Q1 24 | $-20.4M | $-102.3M |
| Q4 25 | $78.7M | $-47.3M | ||
| Q3 25 | $25.9M | $-117.6M | ||
| Q2 25 | $43.4M | $-79.6M | ||
| Q1 25 | $-29.6M | $-133.8M | ||
| Q4 24 | $127.4M | $-116.7M | ||
| Q3 24 | $166.0M | $-63.8M | ||
| Q2 24 | $44.9M | $-83.4M | ||
| Q1 24 | $-21.7M | $-109.0M |
| Q4 25 | 352.4% | -133.1% | ||
| Q3 25 | 93.1% | -2272.5% | ||
| Q2 25 | 201.6% | -413.9% | ||
| Q1 25 | -145.6% | -907.4% | ||
| Q4 24 | 468.2% | -2567.7% | ||
| Q3 24 | 432.1% | -244.6% | ||
| Q2 24 | 131.0% | -578.5% | ||
| Q1 24 | -58.6% | -789.9% |
| Q4 25 | 37.4% | 3.5% | ||
| Q3 25 | 1.7% | 4.7% | ||
| Q2 25 | 2.9% | 16.4% | ||
| Q1 25 | 4.3% | 12.4% | ||
| Q4 24 | 23.9% | 28.6% | ||
| Q3 24 | 7.8% | 17.5% | ||
| Q2 24 | 1.3% | 8.2% | ||
| Q1 24 | 3.7% | 48.2% |
| Q4 25 | 5.49× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 2.57× | — | ||
| Q1 25 | -2.49× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | 6.13× | — | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | -1.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
